EconPapers    
Economics at your fingertips  
 

Urinary Biomarkers of Exposure to Volatile Organic Compounds from the Population Assessment of Tobacco and Health Study Wave 1 (2013–2014)

Víctor R. De Jesús, Deepak Bhandari, Luyu Zhang, Christopher Reese, Kimberly Capella, Denise Tevis, Wanzhe Zhu, Arseima Y. Del Valle-Pinero, Guy Lagaud, Joanne T. Chang, Dana van Bemmel, Heather L. Kimmel, Eva Sharma, Maciej L. Goniewicz, Andrew Hyland and Benjamin C. Blount
Additional contact information
Víctor R. De Jesús: Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control & Prevention, Atlanta, GA 30341, USA
Deepak Bhandari: Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control & Prevention, Atlanta, GA 30341, USA
Luyu Zhang: Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control & Prevention, Atlanta, GA 30341, USA
Christopher Reese: Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control & Prevention, Atlanta, GA 30341, USA
Kimberly Capella: Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control & Prevention, Atlanta, GA 30341, USA
Denise Tevis: Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control & Prevention, Atlanta, GA 30341, USA
Wanzhe Zhu: Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control & Prevention, Atlanta, GA 30341, USA
Arseima Y. Del Valle-Pinero: Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD 20993, USA
Guy Lagaud: Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD 20993, USA
Joanne T. Chang: Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD 20993, USA
Dana van Bemmel: Office of Science, Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD 20993, USA
Heather L. Kimmel: National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD 20892, USA
Eva Sharma: Westat, 1600 Research Boulevard, Rockville, MD 20850, USA
Maciej L. Goniewicz: Division of Cancer Prevention and Population Sciences, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY 14263, USA
Andrew Hyland: Division of Cancer Prevention and Population Sciences, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY 14263, USA
Benjamin C. Blount: Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control & Prevention, Atlanta, GA 30341, USA

IJERPH, 2020, vol. 17, issue 15, 1-12

Abstract: Volatile organic compounds (VOCs) are ubiquitous in the environment. In the United States (U.S.), tobacco smoke is the major non-occupational source of exposure to many harmful VOCs. Exposure to VOCs can be assessed by measuring their urinary metabolites (VOCMs). The Population Assessment of Tobacco and Health (PATH) Study is a U.S. national longitudinal study of tobacco use in the adult and youth civilian non-institutionalized population. We measured 20 VOCMs in urine specimens from a subsample of adults in Wave 1 (W1) (2013–2014) to characterize VOC exposures among tobacco product users and non-users. We calculated weighted geometric means (GMs) and percentiles of each VOCM for exclusive combustible product users (smokers), exclusive electronic cigarette (e-cigarette) users, exclusive smokeless product users, and tobacco product never users. We produced linear regression models for six VOCMs with sex, age, race, and tobacco user group as predictor variables. Creatinine-ratioed levels of VOCMs from exposure to acrolein, crotonaldehyde, isoprene, acrylonitrile, and 1,3-butadiene were significantly higher in smokers than in never users. Small differences of VOCM levels among exclusive e-cigarette users and smokeless users were observed when compared to never users. Smokers showed higher VOCM concentrations than e-cigarette, smokeless, and never users. Urinary VOC metabolites are useful biomarkers of exposure to harmful VOCs.

Keywords: volatile organic compound metabolites; PATH Study; tobacco smoke exposure; e-cigarette users; smokeless tobacco users (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.mdpi.com/1660-4601/17/15/5408/pdf (application/pdf)
https://www.mdpi.com/1660-4601/17/15/5408/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:17:y:2020:i:15:p:5408-:d:390633

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().

 
Page updated 2025-03-19
Handle: RePEc:gam:jijerp:v:17:y:2020:i:15:p:5408-:d:390633